[{"address1": "2001 Market Street", "address2": "Suite 3915 Unit #15", "city": "Philadelphia", "state": "PA", "zip": "19103", "country": "United States", "phone": "267-225-7416", "website": "https://www.contexttherapeutics.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Context Therapeutics Inc., a biopharmaceutical company, develops products for the treatment of solid tumors. Its lead program candidate is CTIM-76, an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6. The company has a collaboration and licensing agreement with Integral Molecular, Inc. for the development of a CLDN6 bispecific monoclonal antibody for cancer therapy. The company was incorporated in 2015 and is headquartered in Philadelphia, Pennsylvania.", "fullTimeEmployees": 12, "companyOfficers": [{"maxAge": 1, "name": "Mr. Martin A. Lehr", "age": 40, "title": "Co-Founder, President, CEO & Director", "yearBorn": 1984, "fiscalYear": 2024, "totalPay": 765596, "exercisedValue": 0, "unexercisedValue": 27676}, {"maxAge": 1, "name": "Ms. Jennifer  Minai-Azary", "age": 46, "title": "CFO & Treasurer", "yearBorn": 1978, "fiscalYear": 2024, "totalPay": 564090, "exercisedValue": 0, "unexercisedValue": 15208}, {"maxAge": 1, "name": "Mr. Alex C. Levit Esq., J.D.", "age": 45, "title": "Chief Legal Officer & Corporate Secretary", "yearBorn": 1979, "fiscalYear": 2024, "totalPay": 541334, "exercisedValue": 0, "unexercisedValue": 14582}, {"maxAge": 1, "name": "Mr. Christopher  Beck M.B.A.", "title": "Senior Vice President of Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.7363, "open": 0.769, "dayLow": 0.7505, "dayHigh": 0.7995, "regularMarketPreviousClose": 0.7363, "regularMarketOpen": 0.769, "regularMarketDayLow": 0.7505, "regularMarketDayHigh": 0.7995, "payoutRatio": 0.0, "beta": 1.894, "forwardPE": -2.7113793, "volume": 172836, "regularMarketVolume": 172836, "averageVolume": 237903, "averageVolume10days": 122760, "averageDailyVolume10Day": 122760, "bid": 0.5389, "ask": 0.988, "bidSize": 2, "askSize": 2, "marketCap": 70534416, "fiftyTwoWeekLow": 0.49, "fiftyTwoWeekHigh": 2.633, "fiftyDayAverage": 0.70088, "twoHundredDayAverage": 0.970825, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -12815320, "profitMargins": 0.0, "floatShares": 39345157, "sharesOutstanding": 89704200, "sharesShort": 1207989, "sharesShortPriorMonth": 1678893, "sharesShortPreviousMonthDate": 1751241600, "dateShortInterest": 1753920000, "sharesPercentSharesOut": 0.0135, "heldPercentInsiders": 0.02325, "heldPercentInstitutions": 0.76787, "shortRatio": 6.19, "shortPercentOfFloat": 0.0163, "impliedSharesOutstanding": 89704200, "bookValue": 0.92, "priceToBook": 0.8546739, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -34207572, "trailingEps": -0.43, "forwardEps": -0.29, "enterpriseToEbitda": 0.335, "52WeekChange": -0.6893281, "SandP52WeekChange": 0.15005577, "quoteType": "EQUITY", "currentPrice": 0.7863, "targetHighPrice": 9.0, "targetLowPrice": 4.0, "targetMeanPrice": 5.2, "targetMedianPrice": 4.0, "recommendationMean": 1.66667, "recommendationKey": "buy", "numberOfAnalystOpinions": 5, "totalCash": 83517048, "totalCashPerShare": 0.931, "ebitda": -38285488, "totalDebt": 167319, "quickRatio": 18.333, "currentRatio": 19.087, "debtToEquity": 0.203, "returnOnAssets": -0.25215, "returnOnEquity": -0.37252998, "freeCashflow": -37020280, "operatingCashflow": -17703620, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "CNTX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "marketState": "CLOSED", "priceEpsCurrentYear": -2.5228608, "fiftyDayAverageChange": 0.08542001, "fiftyDayAverageChangePercent": 0.121875376, "twoHundredDayAverageChange": -0.18452501, "twoHundredDayAverageChangePercent": -0.19007032, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-10-20", "averageAnalystRating": "1.7 - Buy", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1634736600000, "shortName": "Context Therapeutics Inc.", "longName": "Context Therapeutics Inc.", "postMarketChangePercent": 0.432401, "postMarketPrice": 0.7897, "postMarketChange": 0.00339997, "regularMarketChange": 0.05, "regularMarketDayRange": "0.7505 - 0.7995", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 237903, "fiftyTwoWeekLowChange": 0.2963, "fiftyTwoWeekLowChangePercent": 0.60469383, "fiftyTwoWeekRange": "0.49 - 2.633", "fiftyTwoWeekHighChange": -1.8467, "fiftyTwoWeekHighChangePercent": -0.70136726, "fiftyTwoWeekChangePercent": -68.93281, "earningsTimestampStart": 1746648597, "earningsTimestampEnd": 1746648597, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -0.43, "epsForward": -0.29, "epsCurrentYear": -0.31167, "corporateActions": [], "postMarketTime": 1755297009, "regularMarketTime": 1755288001, "exchange": "NCM", "messageBoardId": "finmb_408000800", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 6.79071, "regularMarketPrice": 0.7863, "trailingPegRatio": null, "__fetch_time": "2025-08-16"}]